Anterior ischaemic optic neuropathy.  III. Treatment, prophylaxis, and differential diagnosis.
D000086:Acetazolamide / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications / Q000503:physiopathology; D004487:Edema / Q000188:drug therapy; D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D005451:Fluorescein Angiography; D013700:Giant Cell Arteritis / Q000150:complications / Q000503:physiopathology; D006400:Hematocrit; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007511:Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009900:Optic Nerve / Q000098:blood supply*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000959:Antihypertensive Agents; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D000086:Acetazolamide